BackRein Therapeutics Overview

Rein Therapeutics Common Stock

Rein Therapeutics's common stock is $170K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$172000.00
↑ 54.95% YoYΔ $61000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Rein Therapeutics Common Stock History

Loading

Rein Therapeutics vs. peers: Common Stock Comparison

Loading

Rein Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Rein Therapeutics (RNTX) FAQ

Rein Therapeutics (RNTX) currently reports a common stock of $170K as of September 2026. That compares with $110K in the prior-year period — up 55.0% year over year. Use the charts on this page to explore Rein Therapeutics's common stock history and peer comparisons.

Rein Therapeutics's common stock increased from $110K to $170K — a 55.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rein Therapeutics reported $170K in common stock as of September 2026. That compares with $110K in the prior-year period — up 55.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rein Therapeutics, and consider following RNTX for alerts when major investors trade the stock.

Rein Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $170K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RNTX with unrelated industries.

Questions & Answers